Sio Capital Management’s Actinium Pharmaceuticals ATNM Stock Holding History

Sio Capital Management’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-189,062	Closed	-$1.83M	–	91
2020 Q3	$1.83M	Sell	189,062 -82,526	-30%	-$910K	0.36%	62
2020 Q2	$2.86M	Buy	+271,588	New	+$2.06M	0.84%	44
2019 Q4	–	Sell	-200,105	Closed	-$1.38M	–	71
2019 Q3	$1.38M	Buy	200,105 +35,597	+22%	+$248K	0.44%	50
2019 Q2	$1.21M	Buy	164,508 +153,181	+1,352%	+$1.54M	0.29%	57
2019 Q1	$163K	Hold	11,327	–	–	0.04%	68
2018 Q4	$132K	Buy	+11,327	New	+$193K	0.05%	68
2018 Q3	–	Sell	-29,080	Closed	-$558K	–	64
2018 Q2	$558K	Sell	29,080 -6,793	-19%	-$86.1K	0.31%	45
2018 Q1	$393K	Buy	+35,873	New	+$610K	0.24%	31
2017 Q4	–	Sell	-53,009	Closed	-$915K	–	49
2017 Q3	$915K	Buy	+53,009	New	+$1.16M	0.47%	40
2017 Q1	–	Sell	-54,969	Closed	-$1.44M	–	52
2016 Q4	$1.44M	Buy	54,969 +1,636	+3%	+$51.2K	0.84%	36
2016 Q3	$2.16M	Buy	+53,333	New	+$2.74M	1.49%	23

Other funds holding ATNM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sio Capital Management's ATNM Position: Q4 2020 in Review

Sio Capital Management sold out of Actinium Pharmaceuticals (ATNM) in Q4 2020, closing a stake of 189,062 shares — an estimated $1.83M sold.

Sio Capital Management first reported a position in ATNM in Q3 2016 and held it in 11 quarters. The position peaked at $2.86M in Q2 2020. 48 funds tracked by Wall St. Rank hold ATNM as of Q4 2020.

Sio Capital Management reported no remaining Actinium Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Sio Capital Management sold 189,062 Actinium Pharmaceuticals shares in Q4 2020, an estimated $1.83M.
Sio Capital Management first reported a position in Actinium Pharmaceuticals in Q3 2016 and held it in 11 quarters.
Sio Capital Management's Actinium Pharmaceuticals position peaked at $2.86M in Q2 2020.
48 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2020.

Based on Sio Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.